Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile
Open Access
- 29 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (9) , 2525-2534
Abstract
Systemic sclerosis (SSc) is characterized by multiple clinical manifestations. Vasculopathy is a main disease hallmark and ranges in severity from an exacerbated Raynaud phenomenon to pulmonary arterial hypertension (PAH). The potential involvement of the immune system in SSc-associated vascular abnormalities is not clear. Here, we set out to study SSc-related immune parameters and determine whether and which peripheral T cell subsets associate with vascular severity in SSc patients. Peripheral blood and clinical data were collected from 30 SSc patients, 5 patients with idiopathic PAH and 15 age and sex-matched healthy donors (HD). In this cross-sectional cohort, SSc patients with PAH (n = 15) were matched for their age, sex and medication with SSc patients with no signs of PAH (n = 15). Lymphocyte subsets were quantified by multi-colour flow cytometry. SSc patients exhibited elevated percentages of T peripheral helper cells (Tph), CD4+GZMB+ T cells and decreased levels of Th1 cells compared with HD. Increased presence of both CD4+ and CD8+ exhausted-like (CD28−) T cells, characterized by raised cytokine and cytotoxic signature, was also observed in SSc compared with HD blood. Furthermore, IL-4 expressing CD4+CD8+ T cells were significantly increased in SSc peripheral blood. Interestingly, the presence of PAH in SSc was accompanied by a distinct T helper profile, characterized by raised percentages of Th17 and Tph cells. SSc patients with severe vasculopathy (presence of PAH) exhibited a distinct T cell profile, suggesting a potential role of auto-immune inflammation in SSc vascular complications.Keywords
This publication has 46 references indexed in Scilit:
- LGR5 expressing skin fibroblasts define a major cellular hub perturbed in sclerodermaCell, 2022
- Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panelsAutoimmunity Reviews, 2020
- Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosisCytokine, 2020
- Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma – A reviewAutoimmunity Reviews, 2018
- Current perspectives on the role of CD8+ T cells in systemic sclerosisImmunology Letters, 2018
- Vasculopathy in sclerodermaSeminars in Immunopathology, 2015
- Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional studyRheumatology International, 2011
- Web‐Based Analysis and Publication of Flow Cytometry ExperimentsCurrent Protocols in Cytometry, 2010
- Presence of CD4+CD8+ double‐positive T cells with very high interleukin‐4 production potential in lesional skin of patients with systemic sclerosisArthritis & Rheumatism, 2007
- Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseasesHuman Pathology, 2007